info@novustx-devices.com

Pinpoint Ultrasound
Target your Target

tFUS for Movement Disorders Treatment

Precise Targeting

NovusTX Devices is providing a clinical tFUS system with the capability of targeting sub-mm brain circuits as well as larger cortex region for neuromodulation therapies, depending on various applications.

Non-invasive Treatment

tFUS is a non-invasive intervention for movement disorders treatment. The patient will receive the treatment session in the clinician’s office without hospitalization. No surgery is required.

Superficial and Deep Targeting

Unlike Deep Brain Stimulation and Transcranial Magnetic Stimulation, our system could target areas both superficial (cortex) and deep (sub-cortex) in the brain for different applications.

Platform Technology

Our product aims to treat movement disorders such as Parkinson’s and essential tremors. In the future, other neurological treatments, such as treatment-resistant depression and psychiatric disorders, can be explored. It could also be used as a research tool for exploration study and patient screening.

Founded in March, 2020, NovusTX Devices is a young Albertan company developing clinical focused ultrasound system for the treatment of neurological and psychiatric disorders.

Our solution is based on our patented technology that alters the way of driving ultrasound transducers, our multiaxial driving transducers and phased array system could achieve as a result sub-mm targeting precision at sub-MHz frequencies, which is suitable for non-invasive transcranial focused ultrasound applications.

Ultrasound beam steering is traditionally achieved using phased array systems. Our patented multiaxial driving technique demonstrated, for the first time, that the steering of ultrasound using a single transducer is possible.